Segment Information (Tables)

12 Months Ended

Dec. 31, 2023

Segment Information

Segment information

Year Ended December 31, 2023	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Revenues	$	9,745,400	$	1,366,100		$	-		$	11,111,500
Foreign Sales		2,865,900		894,600			-			3,760,500
Income (Loss) From Operations		720,200		(7,751,200	)		(2,228,900	)		(9,259,900	)
Assets		6,832,400		4,969,400			4,928,700			16,730,500
Long-Lived Asset Expenditures		29,700		102,000			-			131,700
Depreciation and Amortization		84,900		669,100			-			754,000

Six Months Ended December 31, 2022	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Revenues	$	4,608,900		628,900		$	-		$	5,237,800
Foreign Sales		1,322,500		478,200			-			1,800,700
Income (Loss) From Operations		203,500		(3,483,200	)		(902,300	)		(4,137,000	)
Assets		8,622,500		5,174,600			4,272,100			18,069,200
Long-Lived Asset Expenditures		34,300		220,200			-			254,500
Depreciation and Amortization		50,100		330,700			-			380,800

Year Ended June 30, 2022	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Revenues	$	9,981,100	$	1,419,400		$	-		$	11,400,500
Foreign Sales		3,702,400		1,101,400			-			4,803,800
Income (Loss) From Operations		1,475,800		(11,369,500	)		(1,650,400	)		(11,544,100	)
Assets		9,538,600		5,077,500			6,391,800			21,007,900
Long-Lived Asset Expenditures		92,500		732,100			-			824,600
Depreciation and Amortization		96,300		591,900			-			688,200

Geographical Information

	Year Ended
	December 31, 2023
	Revenue (a)		Long-Lived Assets
United States	$	7,351,000	$	1,414,200
All Other Foreign Countries		3,027,500		-
Germany		733,000		1,007,500
Total	$	11,111,500	$	2,421,700

	Six Months Ended
	December 31, 2022
	Revenue (a)		Long-Lived Assets
United States	$	3,437,000	$	1,710,000
All Other Foreign Countries		1,454,700		-
Germany		346,100		885,000
Total	$	5,237,800	$	2,595,000

Income (loss) from operations before discontinued operations and income taxes

Year ended December 31, 2023	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	720,200	$	(7,751,200	)	$	(2,228,900	)	$	(9,259,900	)
Other income (expense), net		10,500		14,300			145,300			170,100
Income (Loss) from operations before discontinued operations and income taxes	$	730,700	$	(7,736,900	)	$	(2,083,600	)	$	(9,089,800	)

Six Months ended December 31, 2022	Benchtop Laboratory Equipment			Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	203,500		$	(3,438,200	)	$	(902,300	)	$	(4,137,000	)
Other (expense) income, net		(28,200	)		3,600			88,500			63,900
Income (Loss) from operations before discontinued operations and income taxes	$	175,300		$	(3,434,600	)	$	(813,800	)	$	(4,073,100	)

Year ended June 30, 2022	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	1,475,800	$	(11,369,500	)	$	(1,650,400	)	$	(11,544,100	)
Other income, net		194,000		(3,100	)		71,500			262,400
Income (Loss) from operations before discontinued operations and income taxes	$	1,669,800	$	(11,372,600	)	$	(1,578,900	)	$	(11,281,700	)